Circulating S100A8/A9 Levels Reflect Intraocular Inflammation in Uveitis Patients.

Yu-Qin Wang,Xiao-Dan Dai,Yun Ran,Ying Cao,Chun-Lin Lan,Ji-Tian Guan,Chang Liu,Feng-Mei Yang,Yi-Jing Gan,Bai-Jing Liu,Ai-Wu Fang,Dan Lin,Xian-Hui Gong,Ren-Zhe Cui,Zi-Bing Jin,Jia Qu,Fan Lu,Zai-Long Chi
DOI: https://doi.org/10.1080/09273948.2018.1538461
2018-01-01
Ocular Immunology and Inflammation
Abstract:Purpose: To investigate whether there is an association between circulating S100A8/A9 levels and uveitis activity. Methods: A total of 549 plasma samples were collected from uveitis patients and non-uveitic controls. Results: S100A8/A9 plasma levels were elevated in uveitis patients compared to non-uveitic controls (P < 0.001). S100A8/A9 plasma levels in patients with active acute anterior uveitis (AAU) were significantly elevated and remarkably decreased in parallel with the severity of intraocular inflammation after corticosteroid treatment (P < 0.001). S100A8/A9 plasma levels were also higher in AAU patients with ankylosing spondylitis (AS) than in patients without AS (P = 0.02). S100A8/A9 plasma levels were significantly increased in uveitis patients with elevated C-reactive protein (CRP, P = 0.004) or erythrocyte sedimentation rates (ESR, P = 0.049) levels compared to uveitis patients with normal CRP or ESR values. Conclusion: Circulating S100A8/A9 might be a useful biomarker for the measurement of intraocular inflammation.
What problem does this paper attempt to address?